Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : JNJ save search
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-18 (Crawled : 18:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
biopharma platform
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Compass Diversified-Backed The Honey Pot Co. Strengthens Its Board With The Appointment of Three New Directors
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
CODI | News | $22.33 0.86% 0.0% 190K
|
Finance
|
| O: 0.36%
H: 0.0%
C: 0.0%
pot honey
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
companies biopharma platform
Health eCareers and AAPPR Expand Partnership to Advance Physician and Provider Recruitment and DE&I Efforts
Published: 2024-04-17 (Crawled : 21:00) - j2global.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
partnership health
MustGrow Biologics to Present at the Planet MicroCap Showcase
Published: 2024-04-17 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
microcap
Biopharma Layoff Tracker 2024: Fujifilm, Genentech, Sanofi and More Cut Staff
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
RLYB | $1.68 -4.55% -4.76% 350K
|
|
| O: -4.44%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
VXRT | $0.836 -3.48% -3.6% 880K
|
Health Technology
|
| O: -0.49%
H: 2.25%
C: -2.25%
TXMD | $1.98 4.76% 4.55% 5.7K
|
Health Technology
|
| O: 2.63%
H: 3.59%
C: -3.08%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: -1.33%
NKTR | $1.3 -3.7% -3.85% 3.6M
|
Health Technology
|
| O: -0.67%
H: 1.35%
C: -8.78%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.17%
H: 0.39%
C: 0.33%
GLPG | $28.9 -1.1% -1.11% 140K
|
Health Technology
|
| O: -0.14%
H: 0.17%
C: -0.78%
AMRN | $0.8799 -4.06% -4.23% 1M
|
Health Technology
|
| O: 3.69%
H: 0.0%
C: 0.0%
GOOGL | News S | $155.97 0.32% 0.32% 19M
|
Technology Services
|
| O: 1.03%
H: 0.94%
C: -0.1%
GOOG | News S | $157.49 0.39% 0.39% 14M
|
Technology Services
|
| O: 0.97%
H: 0.95%
C: -0.2%
OCX J | $2.52 -2.7% -2.78% 37K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: -5.47%
biopharma sanofi
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: -1.48%
H: 1.08%
C: 0.96%
companies biopharma platform
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | $27.885 1.0% 0.99% 2.1M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
reminyl pharma acquisition
Prostate Cancer: Advancements in Prevention and Treatment Drive Global Market Growth
Published: 2024-04-17 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.12%
H: 0.51%
C: 0.51%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
treatment global growth market
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
Published: 2024-04-16 (Crawled : 21:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
stelara fda biosimilar approval teva
J&J Narrowly Misses Q1 Revenue on Lower-Than-Expected Stelara Sales
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
sales revenue stelara
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Co...
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
biopharma platform
Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
XOMA | News | $24.96 2.93% 2.84% 15K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: -0.97%
companies biopharma platform
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
RXRX | $7.41 -0.8% -0.81% 2.9M
|
Professional, Scientific, and T...
|
| O: -9.4%
H: 2.1%
C: -0.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
commercial
Johnson & Johnson Reports Q1 2024 Results
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
results
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
Published: 2024-04-16 (Crawled : 12:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
year
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -3.66%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: -1.29%
H: 1.91%
C: 1.27%
darzalex sales first for
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.